Skip to main content
David Garcia, MD, Hematology, Seattle, WA, UW Medicine/University of Washington Medical Center

DavidAGarciaMD

Hematology Seattle, WA

Professor, Medicine, U of WA Sch of Med

Dr. Garcia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Garcia's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology, 2012 - 2013
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1993 - 1996
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 1993

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2012 - 2025
  • ID State Medical License
    ID State Medical License 2022 - 2024
  • NM State Medical License
    NM State Medical License 1999 - 2015
  • MD State Medical License
    MD State Medical License 1996 - 2000

Publications & Presentations

PubMed

Abstracts/Posters

  • Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis
    David A. Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia
    David A. Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • D-Dimer As a Prognostic Biomarker for Venous Thromboembolism after Hematopoietic Cell Transplantation
    David A. Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Long-Term Management of VTE: The First Six Months and Beyond 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • The HAS-RISC Score for Venous Thromboembolism (VTE) Risk Stratification in Newly Diagnosed Multiple Myeloma Patients Starting Immunomodulatory Drugs (IMID) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Long-Term Management of VTE: The First Six Months and Beyond 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Join now to see all

Press Mentions

  • No Decrease in DVT Risk with Adjunctive Pneumatic Compression
    No Decrease in DVT Risk with Adjunctive Pneumatic CompressionFebruary 18th, 2020

Other Languages

  • Spanish

Hospital Affiliations